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Abstract 
Magnetite nanoparticles are of great interest for biomedical applications such as contrast agents in MRI, drug delivery, gene 
therapy and tissue engineering. In this study, in order to obtain nanoparticles with narrow size distribution and united shape, 
reverse coprecipitation method was done under ultrasound. Structural analysis was done using XRD and FTIR. The XRD result 
was analyzed using Scherrer method and formation of spinel structure with ܨ݀͵݉ was confirmed. The crystallite size and lattice 
parameters were calculated 17.7nm and 8.358 ܣ௢  respectively. FTIR peaks were observed in ۵٧۵  ܿ݉ିଵand  ۴۴١ ܿ݉ିଵ wave 
number and confirms the structure. Magnetic properties of the MNPs was studied using VSM and the saturation magnetization 
(ܯ௦) and the coercive field of the MNPs is 63.13݁݉ݑȀ݃ and ͻǤͳܱ݁ respectively which indicates appropriate magnetic properties 
in biomedical applications. Transmission electron microscope (TEM) was done to observe the morphology of magnetite 
nanoparticles. 
© 2015 The Authors. Published by Elsevier Ltd. 
Peer-review under responsibility of the organizing committee of UFGNSM15. 
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1. Introduction 
During the last decade, the application of nanotechnology to medicine for diagnosis and therapy has emerged as a 
promising new field, often referred to as nanomedicine. A wide selection of nano-sized constructs has been 
developed for applications in drug delivery, imaging, and tissue engineering, Kempe et al. (2010) . Among the 
different chemical composition nanomaterials superparamagnetic iron oxide nanoparticles are certainly the most 
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promising material for medical applications such as cellular labeling, bio-assay, imaging, as drug carriers and for 
hyperthermia treatment. First, their tunable core sizes, ranging from a few up to tens of nanometers, allow control of 
the properties appropriate to the intended application. For example, extremely small sized iron oxide nanoparticles 
(d < 4 nm) can be used as T1 magnetic resonance imaging (MRI) contrast agents, whereas 10 nm iron oxide 
nanoparticles are more efficient T2 MRI contrast agents, de Montferrand et al. (2013)  . 
Magnetite nanoparticles can be synthesized using a lot of different methods such as thermal decomposition, 
microemulsion and coprecipitation. Among all these methods, coprecipitation is an appropriate one using aqueous 
solutions of ܨ݁ூூ  and ܨ݁ூூூ . This method does not produce toxic solution or medium, does not need complex 
precursors and is done in temperatures under ͳͲͲԨ. This method can be used in mass production. All these reasons 
make coprecipitation method important in industrial scale. However broad size distribution is one of the issues of 
this method and might be due to complex paths in the formation of magnetite particles, Ahn et al. (2012) .    
Magnetite received more attention due to its potential applications in nanobiotechnology such as using both as a tag 
for sensing and imaging, and as an active agent for antitumor therapy. However, for high performance in biological 
applications, MNPs should be spherical, biocompatible, superparamagnetic and have narrow size distributions and 
moderate size, high crystallinity, large surface areas (for maximal protein or enzyme binding), high magnetic 
saturation to provide maximum signal, and good dispersion in liquid media, Guo et al. (2009). Iron oxide 
nanoparticles meet these requirements. The advantage they have over other magnetic nanoparticles is that they 
present low toxicity, since Fe exists in the human body, Filippousi et al. (2013). 
By incorporation into standard scaffolds pioneering magnetic scaffolds can be produced. Under an external 
magnetic field, the magnetic moment of the magnetic scaffolds can be continuously controlled. This allows 
reloading of the scaffold from an external supervising center with MNPs that can be coupled to bioactive molecules 
such as tissue GFs facilitating and orchestrating the degree and type of tissue growth, Panseri et al. (2012). 
The crystal structure of magnetite (ܨ݁ଷ ସܱ) is inverse spinel and the space group is ܨ݀ത͵݉. The general formulation 
of inverse spinel is ሺܻሻሾܻܺሿ ସܱ where in ܨ݁ଷ ସܱ , ܺ ൌ ܨ݁ூூ and ܻ ൌ ܨ݁ூூூ and the brackets and parentheses indicate 
octahedral and tetrahedral atomic sites respectively. 8 tetrahedral sites are distributed between ܨ݁ூூ and ܨ݁ூூூatoms, 
Kempe et al. (2010), de Montferrand et al. (2013) .   
Magnetite, with an inverse spinel structure, can be synthesized by well-defined processes, such as the thermal 
decomposition, microemulsion, hydrothermal, and coprecipitation methods. Among the various techniques for 
magnetite synthesis, the coprecipitation method is a convenient way to synthesize magnetite nanoparticles from an 
aqueous iron salt (Fe 2+ + Fe 3+) solution; a base is simply added under an inert atmosphere at room temperature. The 
coprecipitation process does not produce or use any toxic intermediates or solvents, does not require precursor 
complexes, and proceeds at temperatures under 100 °C. This process has been recognized for its industrial 
importance because of its ability to be scaled up, its reproducibility, and its eco-friendly reaction conditions. 
However, it yields particles with a broad size distribution, probably because of the complicated sets of pathways that 
lead to the formation of magnetite, Ahn et al. (2012). 
In this study magnetite nanoparticles were synthesized by coprecipitation method under ultrasonic condition to 
obtain uniform and narrow sized magnetite nanoparticles and overcome the most important issue using 
coprecipitation method.  
2. Experimental 
2.1. Synthesis of magnetite nanoparticles 
	ଶǤ Ͷଶ and  	ଷǤ ͸ଶ were dissolved in 60ml of HCl (0.167M). The solution was then added to a 100ml 
NaOH(1M) dropwise, under mechanical stirring(1000rpm) and in an ultrasonic bath. The black magnetite 
precipitate was obtained and remained under mechanical stirring and in an ultrasonic bath for 30 minutes. The 
precipitate was then separated by a permanent magnet and washed with distilled water.   
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2.2. Characterization 
The obtained magnetite nanoparticles were characterized by X-ray diffraction (XRD) (Philips-PW3710) using Co 
KȽ radiation (ɉ ൌ ͳǤ͹ͺͺιܣ). For Fourier Transform Infrared spectrum (FTIR) (Bruker-Dector33) measurement, the 
samples were blended with KBr and the wave number range was 400-4000ିଵ . The magnetic measurement was 
carried out using a vibrating sample magnetometer (VSM) (Meghnatis Daghigh Kavir, MDK6). Transmission 
electron microscope (TEM) (Zeiss - EM 900) was done to observe the morphology of magnetite nanoparticles.  
3. Result and discussion 
3.1. X-ray diffraction (XRD) 
X-ray diffraction (XRD) pattern of the MNPs is shown in Fig. 1. 
According to Scherrer, if the crystallites in a powder are sufficiently small, the maxima of diffraction pattern are 
broadened by an amount inversely proportional to the crystallite size, and measurement of additional broadening 
thus gives a means of estimating the size through the formula, J. I. and Wilson (1978)  
ߝ ൌ ݇ߣܾܿ݋ݏߠ 
where ߝ is the apparent crystallite size, ߣ is the wavele ngth of the radiation, b is the additional broadening(in 
radius), and ߠ is the Bragg angle, J. I. and Wilson (1978). 
The calculated crystallite size using Scherrer formula of the synthesized MNPs is approximately 16nm.  
 The diffraction peaks were seen at ʹɅ ൌ ʹͳιǡ ͵ͷιǡ Ͷͳιǡ ͷͲιǡ ͸͵ιǡ ͸͹ιǡ ͹ͷι which can be indexed to (111), (220), 
(311), (400), (422), (511), (440). The diffraction peaks confirm the spinel structure of the synthesized MNPs 
 
Fig. 1. X-ray diffraction pattern and reitveld refined pattern of MNPs. 
3.2. Fourier transform infrared spectrum (FTIR) 
Fourier transform infrared spectrum (FTIR) is done to determine the structural characterization of the MNPs. 
Figure 2 shows the FTIR spectra of the MNPs in wave number range of ͶͲͲ െ ͶͲͲͲܿ݉ିଵ . According to Waldron, 
Waldron (1955)ferrites can be considered as crystals with continuous bonds; i.e. the atoms are bonded together with 
an equal force (ionic, covalent or van der vales force). Under ͳͲͲͲܿ݉ିଵ, normally there are 2 peaks in ferrites, 
which indicate the internal bonds of ferrites. ͶͶͳͷͷ͹ܿ݉ିଵ  are related to Fe-O bonds and are attributed to 
octahedral and tetrahedral sites respectively. The reason of witnessing 2 peaks for one bond (Fe-O) is attributed to 
the difference in the bond length of the atoms in two different atomic sites. The two peaks confirm the spinel 
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structure of the MNPs and validate the XRD result. The ͵͵͹ͳܿ݉ିଵ peak is attributed to O-H bond and is most 
likely because of the presence of water. 
 
 
Fig. 2. FTIR spectra of the synthesised MNPs. 
3.3. Magnetic characterization 
The hysteresis loop of the MNPs is shown in fig. 3, and is done using a vibrating sample magnetometer (VSM). 
The saturation magnetization (ܯ௦) and the coercive field of the MNPs is 63.13݁݉ݑȀ݃ and ͻǤͳܱ݁, indicating high 
saturation magnetization and superparamagnetic behavior.  
 
 
Fig. 3. Magnetic hysterisis loop of synthesized MNPs. 
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3.4. Transmission electron microscope (TEM) 
As indicated in Fig. 4, the particles are spherical and the size of the MNPs is approximately 10-12nm with a 
narrow size distribution. 
 
Fig. 4. TEM image of the synthesised magnetite. 
4. Conclusion 
In this study, MNPs were synthesized by sonochemical coprecipitation method. XRD and FTIR analysis 
confirmed the formation of spinel structure. Magnetic behavior of the MNPs was studied using VSM and confirmed 
the superparamagntic behavior of these MNPs.  
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